MERCK CANADA INC. - Address & business activities
Address:
16750 TransCanada Highway
Kirkland, QC H9H 4M7
Canada
Telephone number:
438-920-8356
-
Contact information in previous versions
-
16750 TransCanada Highway
Kirkland, QC H9H 4M7
Canada
Telephone number:
514-428-2638
-
16750 TransCanada Highway
Kirkland, QC H9H 4M7
Canada
Telephone number:
514-515-1009
-
16750 TransCanada Highway
Kirkland, QC H9H 4M7
Canada
Telephone number:
514-428-2638
Fax number:
514-428-2662
-
16750 TransCanada Highway
Kirkland, BC H9H 4M7
Canada
Telephone number:
604-643-7996
Fax number:
604-643-7900
-
16750 TransCanada Highway
Kirkland, BC H9H 4M7
Canada
Telephone number:
604-643-7996
Fax number:
604-643-7900
-
16750 TransCanada Highway
Kirkland, QC H9H 4M7
Canada
Telephone number:
604-643-7996
Fax number:
604-643-7900
-
16750 TransCanada Highway
Kirkland, BC H9H 4M7
Canada
Telephone number:
604-643-5885
Fax number:
604-643-7900
-
16750 TransCanada Highway
Kirkland, QC H9H 4M7
Canada
Telephone number:
604-643-5978
Fax number:
604-622-5619
-
5033 Marguerite Street
Vancouver, BC V6M 3G9
Canada
Telephone number:
604-643-5978
Fax number:
604-622-5619
-
5033 Marguerite Street
Vancouver, BC V6M 3G9
Canada
Telephone number:
604-643-5913
-
383 37th Avenue, Apt #430
Vancouver, BC V5W 4C1
Canada
Telephone number:
604-643-5913
Description of Activities:
For more than 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world.
In Canada, Merck markets a broad range of vaccines, pharmaceutical and animal health products and is one of the top R&D investors in Canada, with investments totaling $93.58 million in 2020 and more than $1.3 billion since 2000. Based in Kirkland, Québec, Merck employs approximately 592 people across the country. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube and Twitter @MerckCanada.
-
Descriptions of the organization's activity in previous versions:
- For over a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube and Twitter @MerckCanada.
- For over a century, Merck has been working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, biologic therapies, and animal health products. In Canada, Merck markets more than 250 pharmaceutical and animal health products. Merck is a leader in a broad range of areas such as oncology, infectious diseases, diabetes, and vaccines.
Based in Montréal, Québec, Merck employs approximately 810 people across Canada. Merck is one of the top R&D investors in Canada, with investments totaling $25.1 million in 2015 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube and Twitter @MerckCanada.
- For 125 years, Merck has been working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. In Canada, Merck markets more than 250 pharmaceutical and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines and women's health, and is focused on expanding offerings in other areas, including virology, oncology and diabetes.
Based in Montréal, Québec, Merck employs approximately 795 people across Canada. Merck is one of the top R&D investors in Canada, with investments totalling $29.9 million in 2014 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube.
- Today's Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. In Canada, Merck markets more than 250 pharmaceutical and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines and women's health, and is focused on expanding offerings in other areas, including virology, oncology and diabetes.
Based in Montreal, Quebec, Merck employs approximately 775 people across Canada. Merck is one of the top R+D investors in Canada, with investments totalling $22.6 million in 2013 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca.
- Today's Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. In Canada, Merck markets more than 250 pharmaceutical and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines and women's health, and is focused on expanding offerings in other areas, including virology, oncology and diabetes.
Based in Montréal, Québec, Merck employs approximately 975 people across Canada. The Merck Canada manufacturing facility in Québec has been designated by its parent company as a Centre of Excellence for the global production of liquids, ointments and creams. Merck is one of the top R&D investors in Canada, with investments totalling $22.6 million in 2013 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca.
- Today's Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer care and animal health products. In Canada, Merck markets more than 530 pharmaceutical, consumer care and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes.
Based in Montréal, Québec, Merck employs approximately 1150 people across Canada. The Merck Canada manufacturing facility in Québec has been designated by its parent company as a Centre of Excellence for the global production of liquids, ointments and creams. Merck is one of the top R&D investors in Canada, with investments totalling $39.7 million in 2012 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca.
- Today's Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets over 530 pharmaceutical, consumer and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes.
Merck is one of the top R&D investors in Canada, with an investment of $78.6 million in 2010. Merck has a large manufacturing facility in Québec dedicated to the annual production of some 35 million units of its various brands, including Claritin® and Aerius®. Based in Montréal, Québec, Merck employs over 1400 people across Canada. For more information about our operations in Canada, visit www.merck.ca.
- Today's Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets over 530 pharmaceutical, consumer and animal health products and is a leader in a broad range of areas such as cardiology, immunology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes.
Merck is one of the top 25 R&D investors in Canada, with an investment of $95.4 million in 2009. Merck also has a large manufacturing facility in Quebec dedicated to the annual production of some 35 million units including the Claritin and Aerius brands. Based in Montréal, Quebec, Merck employs over 1600 people across Canada. For more information about our operations in Canada, visit www.merck.ca.
*Merck Frosst Canada Ltd. and Schering-Plough Canada Inc. are integrating their operations to form a new organization called Merck.
- Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets over 530 pharmaceutical, consumer and animal health products and is a leader in a broad range of areas such as cardiology, immunology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes.
Merck is one of the top 25 R&D investors in Canada, with an investment of $121 million in 2008 and has one of the largest biomedical research facilities in Canada with the mandate to discover new therapies for the treatment of infectious diseases. Merck also has a large manufacturing facility in Quebec dedicated to the annual production of some 35 million units including the Claritin and Aerius brands. Based in Montréal, Quebec, Merck employs over 1800 people across Canada. For more information about our operations in Canada visit www.merckfrosst.com.